Q2 FY2026 · ended Jun 30, 2026 · Revenue $1.47M, +26.7% YoY · Filed Aug 12, 2026
Lucid Diagnostics Inc. (LUCD) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $1.5 million and a net loss of $11.7 million. Free cash flow was -$11.3 million. As of Jun 30, 2026 it held $33.4 million in cash and investments and $1.4 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- LUCD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1799011
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $1.5M | $1.3M | — | $1.2M | $1.2M |
| Operating income | -$12.8M | -$12.1M | -$14.0M | -$11.8M | -$11.4M |
| Net income | -$11.7M | -$13.9M | -$16.3M | -$10.4M | -$4.4M |
| Diluted EPS | — | — | — | -$0.10 | -$0.08 |
| Operating cash flow | -$11.3M | -$12.1M | -$12.6M | -$10.9M | -$10.5M |
| Free cash flow | -$11.3M | -$12.3M | — | — | — |
| Total assets | $38.9M | $34.1M | $40.4M | $53.2M | $38.7M |
| Total liabilities | $28.0M | $30.1M | $29.5M | $27.4M | $30.8M |
| Stockholders' equity | $10.9M | $4.0M | $10.9M | $25.8M | $7.9M |
| Cash and investments | $33.4M | $27.9M | $34.7M | $47.3M | $31.1M |
| Total debt | $1.4M | $1.6M | $1.8M | $2.0M | $2.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
|
Oct 22, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Listing notice
|
Oct 16, 2026 | Oct 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 22, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 24, 2026 | Jun 24, 2026 |
All 281 Lucid Diagnostics Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.